Abbott Labs' (ABT) Amulet Could Gain 30% Share - BofA Securities

August 31, 2021 8:46 AM EDT Send to a Friend
BofA Securities analyst Bob Hopkins reiterated a Buy rating and $133.00 price target on Abbott Labs (NYSE: ABT) after data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login